A
The startup develops targeted therapeutics for inflammatory skin diseases, vascular malformations, and immuno-oncology endometriosis, utilizing advanced drug formulation techniques to enhance treatment efficacy. Their medications aim to improve patient recovery times and overall quality of life by addressing specific medical needs in these conditions.
Yokohama, Japan
Updated 2 months ago
Funding
$11.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops targeted therapeutics for inflammatory skin diseases, vascular malformations, and immuno-oncology endometriosis, utilizing advanced drug formulation techniques to enhance treatment efficacy. Their medications aim to improve patient recovery times and overall quality of life by addressing specific medical needs in these conditions.